ALDR - Alder Biopharmaceuticals Inc (ALDR) CEO Bob Azelby on Q4 2018 Results - Earnings Call Transcript
Alder Biopharmaceuticals Inc. (ALDR)
Q4 2018 Earnings Conference Call
February 25, 2019 5:00 PM ET
Company Participants
Michael Schaffzin - Stern, Investor Relations
Bob Azelby - Chief Executive Officer
Carlos Campoy - Chief Executive Officer
John Latham - Chief Scientific Officer
Eric Carter - Interim Chief Medical Officer
Conference Call Participants
Beau Miller - RBC Capital Markets
Paul Matteis - Stifel
Jeff Hung - Morgan Stanley
Jessica Fye - JP Morgan
Yanan Zhu - Wells Fargo Securities
Geoffrey Porges - Leerink Partners
Alex Lim - Mizuho
Na Sun - BMO Capital
Danielle Brill - Piper